AR-12286

DRUG3 trials

Sponsors

Aerie Pharmaceuticals, Robert Ritch, MD, LLC.

Conditions

Elevated Intraocular PressureExfoliation SyndromeNormal VolunteersOcular HypertensionOpen Angle Glaucoma

Phase 1

Formulation Comparison in Normal Volunteers

CompletedNCT01250197

Aerie PharmaceuticalsNormal Volunteers

Start: 2010-11-30End: 2010-12-31Target: 18Updated: 2010-12-22

Phase 2

A Study of AR-12286 in Patient With Elevated Intraocular Pressure (IOP)

CompletedNCT00902200

Aerie PharmaceuticalsElevated Intraocular Pressure

Start: 2009-05-31End: 2009-09-30Updated: 2014-04-21

A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma

CompletedNCT01936389

Robert Ritch, MD, LLC.Exfoliation Syndrome, Ocular Hypertension, Open Angle Glaucoma

Start: 2013-09-30End: 2014-10-31Updated: 2018-11-16